Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients

BACKGROUND: Whether radiotherapy only for primary lung tumor (RTPLT) after epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) therapy improves survival of treatment naïve advanced EGFR-mutant lung adenocarcinoma (LAD) patients with/without polymetastasis. MATERIALS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Kuo-Hsuan, Huang, Jing-Wen, Tseng, Jeng-Sen, Chen, Kuan-Wen, Weng, Yih-Chyang, Yu, Sung-Liang, Yang, Tsung-Ying, Huang, Yen-Hsiang, Chen, Jeremy J W, Chen, Kun-Chieh, Chang, Gee-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006910/
https://www.ncbi.nlm.nih.gov/pubmed/33790577
http://dx.doi.org/10.2147/OTT.S300267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006910/
https://www.ncbi.nlm.nih.gov/pubmed/33790577
http://dx.doi.org/10.2147/OTT.S300267

Ejemplares similares